Health Sciences

1. The award will be granted to the lead author(s). a. In the case where lead authorship is shared, the award will be shared equally between the authors.
2. Lead author(s) of the article must have a primary appointment with a CIHR eligible institution or a Canadian institution.
3. Lead author(s) can be a Canadian citizen, permanent resident, or a citizen of another country.  
4. The article must be original research or original research synthesis and must have been published (i.e., published and accessible online, not accepted to be published at a future date) in a peer-reviewed journal between January 1, 2023, and December 31, 2023. 
5. At least one author of the article (lead or co-author) must be affiliated with a CIHR Eligible institution to receive the funds. 
6. Applicants may only submit one article per competition year. This article must not have been submitted in the previous competition cycle. 
7. Applicants cannot have previously received the Article of the Year award. 
8. Articles involving members of the CIHR Governing Council, CIHR Scientific Directors and CIHR and institute staff as lead author (first or last) are ineligible for this award.

Nominee will have demonstrated highly original, sustained and reproducible scholarship that has made major contributions to the understanding of diabetes, its treatment and/or prevention. Nominee must have MD, PhD, MD/PhD degree or equivalent.

Both U.S. and non-U.S. residents are eligible for award. Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.  

Candidates must be nominated by any professional member of the American Diabetes Association; All Banting nominations must have the following documents uploaded as one .pdf file: Letter of nomination (no more than 400 words), signed by no more than 3 individuals, will be accepted.  Letter of nomination should address criteria for selection. Nominee’s biography. Nominee’s CV with career and publication highlights. Annotated list of the nominee’s 10 most significant publications.

Medal, grant, presentation and free publication opportunity

This is only open to individuals.

Applicants must indicate one of the following Laureate options as their intended match:

• Bonnie Bassler, Michael Silverman, Peter Greenberg - Quorum sensing, bacterial biology 
• Demis Hassabis,  John Jumper – Protein structure prediction, artificial intelligence in research
• José Belizán  - Perinatal health, evidence-based interventions, community inclusion in research
• Christopher Mushquash  - Culturally- and contextually-led research and interventions, mental health and substance abuse
• Gelareh Zadeh  - Brain tumour biology, treatment and early detection

Submissions should include a 2 minute video proposal for your research presentation, plus a 100 word summary explaining how your science relates to one or more of this year’s laureates and what you hope to learn from your interactions with them. If you wish to use slides in your video we request no more than two (2) be included.

Early Career Investigator Competition

Successful nominees will have produced a focused, cohesive body of scientific research which has made a significant impact in health research. Consideration will also be given to a nominee’s contributions to the growth and enrichment of the Canadian research community.

The primary nominator must be a CAHS Fellow. In addition to providing a letter of nomination that introduces the nominee and co-nominators, the primary nominator accepts responsibility to co-ordinate the entire application. Two co-nominators, who would normally be an institutional leader from the nominee’s institution and a colleague from a different institution, national or international, will attest their support of the nomination.

● Data sheet on nominee (pg. 1), citation and key words (pg. 2), succinct summary of nominee's accomplishments and contributions (pg. 3)

● Letters of nomination from three (3) nominators (including the primary nominator which appears first)

● Personal statement from the nominee on the commitment s/he is willing to make to advance academic health sciences (page 4). A note for the guidance of the nominee in this regard is included in this nomination package (page 5) and should be provided to the nominee by the first nominator

● Curriculum vitae of the nominee that clearly identifies trainees as authors of papers by means of an asterisk on the trainee’s name.

March 6, 2024 (anticipated)

• Their work may be a single meritorious contribution or a lifetime of superior accomplishments. Pioneers in their field, they are role models who inspire young Canadians to pursue careers in the health sciences.
• The CMHF perceives health leadership to be inclusive of many professions and roles including doctors, researchers, nurses, dentists, pharmacists, policy makers - to name only a few. Nominations of Canadians, living or posthumous, who meet the criteria from the many aspects of health are encouraged.
• The CMHF recognizes that contributions deemed worthy of Laureate status evolve over time and differ across diverse communities, requiring that the selection process recognize excellence in the context of time and place.
• Up to six individuals may be selected for induction annually; only one individual may be inducted posthumously each year.

$20,000 CAD; Medal

Nominations are accepted from any Canadian individual or organization and is not limited to industry. A secondary nominator is required for the nomination to be considered and cannot originate from a current member of the Medal of Honour Committee.

The nomination deadline is June 21 of the award granting year. Any nomination submitted may be considered for up to two award cycles. The nominee’s work/research must have been performed in Canada by a Canadian Resident and have achieved international recognition for its contribution to the advancement of knowledge in the health sciences, health policy and/or the improvement of therapeutics and healthcare.

Each nomination package includes a letter of recommendation from each nominator, the nominee’s Curriculum Vitae, and supplemental material that supports the nomination.

Members in good standing of Friends of Canadian Institutes of Health Research (FCIHR) or the Canadian Academy of Health Sciences (CAHS) may make nominations, at any time, without limit. Presidents and Deans of Medicine of Canadian universities are canvassed annually to nominate suitable candidates. Scientific Directors of Research Institutes are also welcome to submit nominations. Nominations from Universities and Research Centres outside of Canada will also be considered. There is no limit to the number of nominations that may be submitted. Nominations will be considered for up to three consecutive years, after which a new submission is required.

NOMINEE DETAILS: Contact and basic professional information

CITATION (Max. 150 words): 1-2 sentence statement identifying nominee's distinct body of research. RESEARCH SUMMARY (Max. 1000 words): Summary of nominee's scientific body of work and their impact on global health and health equity.

TOP FIVE: Top 5 publications related to the research summary, with a brief summary of the impact/importance

SHORT CV: 10-20 pages

NOMINEE IN CONTEXT (Max. 1000 words): Contextualize the nominee's body of work, including:

Online information sessions are available in July, August and early September for those interested in the award and nomination.  – see website

$30,000 USD

You must have received their PhD no more than 10 years prior to 31 December 2024. You must have made ground-breaking research and a significant contribution advancing clinical and experimental investigations. You must be nominated by senior scientists.

Nominations are submitted on line. Along with the registration form, companies will be asked to please send a cheque or make a direct deposit in the amount of $2,500  to Innovation Life Canada. Universities will be asked to send a cheque in the amount of $500. The registration fees will help cover the cost of the files analysis.

Up to $150,000 USD

The MMRF Fellowship Program does NOT require applicants to be US citizens. Researchers with a Ph.D., M.D. or equivalent degree at the post-doctorate, clinical fellow, or junior faculty level are encouraged to apply.  Post-doctorate and medical fellows applying for the award must work under the supervision of a research mentor in the multiple myeloma field. Applicants must have obtained their highest degree within 10 years of the application date. Applicants may not hold a position higher than Assistant Professor. Applicants who are beginning studies in the multiple myeloma field must have a research sponsor/mentor at their institution who is active in the multiple myeloma field, and who can provide guidance to the applicant in the proposed area of research.

Nominations are accepted from physicians and scientists from around the world. U.S. and non U.S. citizens are eligible to be nominated. Multiple nominations from an institution are permitted. Nominations are submitted online.

To complete a nomination, please provide the following information in the on-line form. All attachments must be in .PDF format.

• The title and institution of each nominee
• A C.V. and bibliography to upload for each nominee (.pdf)
• Nominator Contact Information
• A suggested citation for the award (maximum fifty words)
• Description of the nominee(s) research as it relates to the nomination, including the top five references related to the research. (.pdf)
• Responses to the following two questions in the nomination form:
  • Why are you nominating this person or group over others who have made significant contributions in the same area of research?
  • If nominating an individual, please comment on whether you believe it might be appropriate for others to share in this award, and if so, please describe their contributions.
• 2 letters in support of the nomination to upload (.pdf)